Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending December 3, 2021

Overall drug TRx: +19.3%

Vascepa
TRx 81,984; +19.8% (+13,532) w/w; -6.3% y/y
NRx 35,925; +25.0% (+7,188) w/w; -6.8% y/y
Ref 46,058; +16.0% (+6,344) w/w; -5.8% y/y

Lovaza (Generic & Brand)
TRx 65,284; +23.3% (+12,334) w/w; -0.9% y/y
NRx 32,462; +31.5% (+7,780) w/w; -2.2% y/y
Ref 32,822; +16.1% (+4,554) w/w; +0.3% y/y

Generic Vascepa
TRx 23,411; +20.2% (+3,941) w/w; As % of total V: 22.2%
NRx 12,829; +21.1% (+2,238) w/w; As % of total V: 26.3%
Ref 10,582; +19.2% (+1,702) w/w; As % of total V: 18.7%

Generic Vascepa by Manufacturer
Hikma - TRx 13,470 (+1,923); Generic share 57.5%; Total V share 12.8%
Reddy - TRx 9,941 (+2,018); Generic share 42.5%; Total V share 9.4%

Vascepa + Generic Vascepa
TRx 105,395; +19.9% (+17,473)
NRx 48,754; +24.0% (+9,426)
Ref 56,641; +16.6% (+8,047)